Translating Evidence Into Action: Nonsteroidal MRAs in Patients With HF
Muthiah Vaduganathan, MD, MPH
Koichiro Kinugawa, MD
Michael Böhm, MD
Understanding the Mechanisms Behind Resistant Hypertension
Steve Jackson, PharmD
Jan Basile, MD
Michael J. Bloch, MD, FAHA, FASH, FNLA, FSVM, FACP
Unblocking Clinical Inertia: The CMI Era in oHCM Care
Iacopo Olivotto, MD
Elena Arbelo
Silvia Aguiar
Understanding Residual Cardiovascular Risk in CKD and T2D
John W. Ostrominski, MD, MPH
Leadoff Hitter – Spotting High-Risk Players
J.A. Randy Englert, MD, FACC
Extra Innings – Sustaining Victory Beyond the First Game
Matthew Malachowski, Pharm. D., MHA
Turning the Double Play – Comprehensive Secondary Prevention
Small Ball Wins Games – Combination Therapy for Goal Attainment
Crossing Home Plate – Building a Winning Team Culture
ASCVD Playbook | Closing the Gaps, One Inning at a Time
Swing for the Fences – LDL-C as the Power Hitter
The Limits of Traditional AFib Prediction Models in ATTR-CA
A Multi-Pillar Approach to Cardio-Renal Risk Reduction
Brian P. McDonough, MD, FAAFP
Anu Lala, MD
Martha Gulati, MD, MS, FACC, FAHA
Quality of Life Conversations in ATTR-CM Care
Kevin S. Shah, MD
Supporting Whole-Body Health Through the Gut
Shelina Ramnarine, PhD
Terri DeNeui, DNP, APRN, ACNP-BC
SPIRIT-HF: Does Spironolactone Improve Outcomes in HFpEF and HFmrEF?
Loading...
NEW FEATURES:
Tell us what you think by using our Feedback button
We're glad to see you're enjoying Global Cardiology Academy… but how about a more personalized experience?
Press cancel to remain on Global Cardiology Academy. Press the link below or the continue button to keep going.